To include your compound in the COVID-19 Resource Center, submit it here.

CK-2127107: Phase II started

The partners began a double-blind, placebo-controlled, 2-way crossover, U.S. Phase II trial to

Read the full 138 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE